Statistics for Fortress Biotech (id:5647 FBIO)

Valuation metrics

Market cap

44.44M

Enterprise value

12.37M

Trailing P/E (ttm)

-0.19

Forward P/E

-0.91

PEG ratio

-0.91

Price/Sales (ttm)

0.54

Price/Book (mrq)

1.08

Enterprise Value/Revenue

0.15

Enterprise Value/EBITDA

-0.14

Overview

Shares outstanding

27.60M

Float

16.12M

Shares short

2.62M

% Held by insiders

0.21%

% Held by institutions

0.16%

Average volume (10 days)

402.97K

Average volume (90 days)

Price summary

52-Week low

1.36

52-Week high

4.43

52-Week change

-36.65%

Beta

1.75

50-Day moving average

1.69

200-Day moving average

1.85

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

October 10th, 2023

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-49.25%

Operating margin

-168.76%

Operational effectiveness

Return on assets

-36.41%

Return on equity

-4,326.97%

Income statement

Revenue (ttm)

6.15

Revenue per share (ttm)

6.15

Quarterly revenue growth (yoy)

Gross profit (ttm)

57.85M

EBITDA

-90,308,000.00

Net income to common (ttm)

-49,273,000.00

Diluted EPS (ttm)

-2.96

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

76.20M

Total cash per share (mrq)

3.34

Total debt (mrq)

88.42M

Total Debt/Equity (mrq)

-6.94

Current ratio (mrq)

136.90%

Book value per share (mrq)

1.49

Cash flow

Cash flow statement

-98,939,000.00

Levered free cash flow (LFCF)

-59,199,376.00